Global /India /Healthcare /Drug Manufacturers - General /MEDICAMEQ

Medicamen Biotech Ltd.

MEDICAMEQ

• NSE: MEDICAMEQ • Delayed

254.53INR 2.1%

2.70 USD

As of 20 June 2026, Medicamen Biotech Ltd. has a market cap of $34.12M USD, ranking #33343 globally and #2223 in India. It ranks #3013 in the Healthcare sector, and #1035 in the Drug Manufacturers - General industry.

Global Rank

33343

Country Rank

2223

Sector Rank

3013

Industry Rank

1035

Key Stats

Market Cap

$34.12MUSD

3.22B INR

Enterprise Value

$33.58MUSD

3.17B INR

Revenue (TTM)

$18.23MUSD

1.72B INR

EBITDA (TTM)

$2.0MUSD

188.39M INR

Net Income (TTM)

$822.76KUSD

77.66M INR

EBITDA Margin

11%

Profit Margin

4.5%

PE Ratio

41.5

PS Ratio

1.9

PB Ratio

1.2

EV/EBITDA

16.8

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Rajesh Madan open_in_new

Employees

376

Founded

1993

Website

medicamen.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.1%	-7.1%	4.4%	-29%	-30%	-32%	-44%	-65%	-59%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	MEDICAMEQ Medicamen Biotech Ltd ISIN: INE646B01010 Shares Out.: Shares Outstanding: 13.563M¹ Shares Float: 6.001M² TV: TradingView: NSE: MEDICAMEQ SA: Stock Analysis: NSE: MEDICAMEQ YF: Yahoo Finance: MEDICAMEQ.NS GF: Google Finance: NSE: MEDICAMEQ BA: Barron's: MEDICAMEQ MS: Morningstar: XNSE: MEDICAMEQ	254.53 INR	TV: TradingView: NSE: MEDICAMEQ SA: Stock Analysis: NSE: MEDICAMEQ YF: Yahoo Finance: MEDICAMEQ.NS GF: Google Finance: NSE: MEDICAMEQ BA: Barron's: MEDICAMEQ MS: Morningstar: XNSE: MEDICAMEQ
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	531146 (MEDICAMEQ) Medicamen Biotech Ltd ISIN: INE646B01010 TV: TradingView: BSE: MEDICAMEQ SA: Stock Analysis: BOM: 531146 YF: Yahoo Finance: 531146.BO GF: Google Finance: BOM: 531146 BA: Barron's: 531146 MS: Morningstar: XBOM: 531146	248.15 INR	TV: TradingView: BSE: MEDICAMEQ SA: Stock Analysis: BOM: 531146 YF: Yahoo Finance: 531146.BO GF: Google Finance: BOM: 531146 BA: Barron's: 531146 MS: Morningstar: XBOM: 531146

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medicamen Biotech Ltd.

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 132K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 54K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 44K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 34K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 29K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 28K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 933K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 834K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 803K%	15.1	United States

chevron_leftBack